Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,882,326
  • Shares Outstanding, K 21,312
  • Annual Sales, $ 0 K
  • Annual Income, $ -373,630 K
  • 60-Month Beta -0.41
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.94
Trade MDGL with:

Options Overview Details

View History
  • Implied Volatility 51.48% ( -4.40%)
  • Historical Volatility 60.48%
  • IV Percentile 7%
  • IV Rank 4.60%
  • IV High 156.35% on 02/23/24
  • IV Low 46.42% on 06/06/24
  • Put/Call Vol Ratio 0.15
  • Today's Volume 410
  • Volume Avg (30-Day) 894
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 33,574
  • Open Int (30-Day) 30,094

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -7.55
  • Number of Estimates 9
  • High Estimate -6.52
  • Low Estimate -9.37
  • Prior Year -4.69
  • Growth Rate Est. (year over year) -60.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
208.60 +32.32%
on 06/05/24
295.50 -6.60%
on 06/11/24
+55.95 (+25.42%)
since 05/17/24
3-Month
189.00 +46.04%
on 04/26/24
295.50 -6.60%
on 06/11/24
-7.22 (-2.55%)
since 03/18/24
52-Week
119.76 +130.47%
on 10/27/23
299.98 -7.99%
on 03/15/24
+31.92 (+13.08%)
since 06/16/23

Most Recent Stories

More News
The Best Biotech Stock to Invest $1,000 in Right Now

This stock may not be a slam dunk, but it's looking very promising.

MDGL : 276.01 (-0.26%)
LLY : 891.46 (+0.73%)
NVO : 140.80 (+0.31%)
VKTX : 50.64 (-2.65%)
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.

Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.

MDGL : 276.01 (-0.26%)
LLY : 891.46 (+0.73%)
Where Will Madrigal Pharmaceuticals Be in 3 Years?

The coast is clear for it to grow, for now.

MDGL : 276.01 (-0.26%)
NVO : 140.80 (+0.31%)
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals

Success isn't guaranteed, but both companies could become big winners.

VKTX : 50.64 (-2.65%)
MDGL : 276.01 (-0.26%)
Is Madrigal Pharmaceuticals Stock a Buy?

It's not the most prominent biotech, but it has an important claim to fame.

MDGL : 276.01 (-0.26%)
Madrigal: Q1 Earnings Snapshot

Madrigal: Q1 Earnings Snapshot

MDGL : 276.01 (-0.26%)
2 Under-the-Radar Growth Stocks to Consider

Don't ignore these innovative companies.

MDGL : 276.01 (-0.26%)
AXSM : 76.02 (+0.03%)
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics

These businesses should see good times ahead.

MDGL : 276.01 (-0.26%)
VKTX : 50.64 (-2.65%)
1 No-Brainer Growth Stock to Buy Now

This liver-disease specialist might be significantly undervalued.

MDGL : 276.01 (-0.26%)
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals

Both stocks are pretty risky, but one of them more so than the other.

VKTX : 50.64 (-2.65%)
MDGL : 276.01 (-0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia...

See More

Key Turning Points

3rd Resistance Point 285.07
2nd Resistance Point 282.16
1st Resistance Point 279.09
Last Price 276.01
1st Support Level 273.11
2nd Support Level 270.20
3rd Support Level 267.13

See More

52-Week High 299.98
Last Price 276.01
Fibonacci 61.8% 231.14
Fibonacci 50% 209.87
Fibonacci 38.2% 188.60
52-Week Low 119.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar